1,268
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles

, , , &
Pages 1375-1383 | Received 01 Jan 2009, Accepted 01 Apr 2009, Published online: 16 Oct 2009

References

  • Solly SK, Trajcevski S, Frisén C, Holzer GW, Nelson E, Clerc B, . (2003). Replicative retroviral vectors for cancer gene therapy. Cancer Gene Ther, 10:30–9.
  • Roy I, Holle L, Song W, Holle E, Wagner T, Yu X. (2002). Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anticancer Res, 22:3185–9.
  • Kichler A, Leborgne C, Coeytaux E, Danos O. (2001). Polyethylenimine-mediated gene delivery: A mechanistic study. J Gene Med, 3:135–44.
  • Farrell LL, Pepin J, Kucharski C, Lin X, Xu Z, Uludag H. (2007). A comparison of the effectiveness of cationic polymers poly-l-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC). Eur J Pharm Biopharm, 65:388–97.
  • Basarkar A, Devineni D, Palaniappan R, Singh J. (2007). Preparation, characterization, cytotoxicity and transfection efficiency of poly(dl-lactide-co-glycolide) and poly(dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm, 343:247–54.
  • Brown MD, Schätzlein AG, Uchegbu IF. (2001). Gene delivery with synthetic (non viral) carriers. Int J Pharm, 229:1–21.
  • Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. (1998). DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release, 53:183–93.
  • Li SD, Huang L. (2007). Non-viral is superior to viral gene delivery. J Control Release, 123:181–3.
  • Gao X, Kim KS, Liu D. (2007). Nonviral gene delivery: What we know and what is next. AAPS J, 9:E92–104.
  • Lobenberg R, Araujo L, Kreuter J. (1997). Body distribution of azidothymidine bound to nanoparticles after oral administration. Eur J Pharm Biopharm, 44:127–32.
  • Suri SS, Fenniri H, Singh B. (2007). Nanotechnology-based drug delivery systems. J Occup Med Toxicol, 2:16.
  • Díez S, Tros de Ilarduya C. (2006). Versatility of biodegradable poly(d,l-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm, 63:188–97.
  • Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. (2002). Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J, 16:1217–26.
  • Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH. (1997). Poly(dl-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine, 15:814–7.
  • Mok H, Park TG. (2008). Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method. Eur J Pharm Biopharm, 68:105–11.
  • Evans RK, Xu Z, Bohannon KE, Wang B, Bruner MW, Volkin DB. (2000). Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J Pharm Sci, 89:76–87.
  • Remaut K, Sanders NN, Fayazpour F, Demeester J, De Smedt SC. (2006). Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. J Control Release, 115:335–43.
  • Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. (1989). Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm, 55:R1–4.
  • Sternling CV, Scriven LE. (1959). Interfacial turbulence: Hydrodynamic instability and the Marangoni effect. AIChE J, 5:514–23.
  • Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. (1998). Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm, 24:1113–28.
  • Barichello JM, Morishita M, Takayama K, Nagai T. (1999). Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm, 25:471–6.
  • Yoo HS, Choi HK, Park TG. (2001). Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. J Pharm Sci, 90:194–201.
  • Subrahmanyam M, Kaneco S, Alonso-Vante N, Labhasetwar V, Bonadio J, Goldstein SA, . (1999). Gene transfection using biodegradable nanospheres: Results in tissue culture and a rat osteotomy model. Colloids Surf B Biointerfaces, 16:281–90.
  • Oster CG, Wittmar M, Bakowsky U, Kissel T. (2006). DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method. J Control Release, 111:371–81.
  • del Pozo-Rodríguez A, Delgado D, Solinís MA, Gascón AR, Pedraz JL. (2007). Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity. Int J Pharm, 339:261–8.
  • Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, . (2001). PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Control Release, 71:203–11.
  • Shi K, Cui F, Yamamoto H, Kawashima Y. (2008). Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles. Pharmazie, 63:866–71.
  • Chognot D, Léonard M, Six JL, Dellacherie E. (2006). Surfactive water-soluble copolymers for the preparation of controlled surface nanoparticles by double emulsion/solvent evaporation. Colloids Surf B Biointerfaces, 51:86–92.
  • Prabha S, Zhou WZ, Panyam J, Labhasetwar V. (2002). Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int J Pharm, 244:105–15.
  • Ando S, Putnam D, Pack DW, Langer R. (1999). PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci, 88:126–30.
  • Zhuang FF, Liang R, Zou CT, Ma H, Zheng CX, Duan MX. (2002). High efficient encapsulation of plasmid DNA in PLGA microparticles by organic phase self-emulsification. J Biochem Biophys Methods, 52:169–78.
  • Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. (1999). PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release, 57:171–85.
  • Bilati U, Allémann E, Doelker E. (2005). Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech, 6:E594–604.
  • Peltonen L, Aitta J, Hyvönen S, Karjalainen M, Hirvonen J. (2004). Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles. AAPS PharmSciTech, 5:E16.
  • Barry ME, Pinto-González D, Orson FM, McKenzie GJ, Petry GR, Barry MA. (1999). Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum Gene Ther, 10:2461–80.
  • Panyam J, Labhasetwar V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 55:329–47.
  • Zhang S, Zhao B, Jiang H, Wang B, Ma B. (2007). Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release, 123:1–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.